send to a friend by email
2018-08-16
Sahem weekly trading report (12-16)-08-2018
Al-Quds Index ended this week with a decrease of 0.44% than its previous weekly closing level, to record 541.56 points amid scarce liquidity and weak trading. However, the semi- annual financial disclosures witnessed a momentum during this week, whereby, the number of listed companies in Palestine Securities Exchange PEX that disclosed their financial results constituted for 54.16% from the total number of listed companies in the PEX until now. On the other hand, the legal period granted by the PEX to the listed companies to disclose their H1 financial data has been extended to end on September 01, 2018 instead of August 15, 2018 in order to meet the requirements of the International Financial Reporting Standards IFRS 9, which applying it became mandatory.
Regarding the leading companies’ semi-annual financial data disclosures, the Arab Palestinian Investment Company APIC noted posting net income attributable to the shareholders of the parent company of $5.67 million; up by 8.38% than the corresponding period of 2017. This followed an increase in the company’s sales and services revenue. According to the disclosed figures, APIC records book value BV of $1.24, and P/BV of 1.85x.
Regarding the disclosures of the listed companies in the industry sector, the Arab Company for Paints Products APC noted posting net income of JD0.29 million in H1 2018; down by 58.14% than the corresponding period of 2017. This followed a decrease in the company’s sales and gross income. According to the disclosed figures, APC records BV of JD2.60, and P/BV of 2.50x. On the other hand, the Vegetable Oil Industries Company VOIC announced posting net income of JD3.59 million in H1 2018; down by 6.13% than the corresponding period of 2017. This decrease occurred despite the increase in the company’s sales, gross and operating income, while followed the losses of currency valuation exchange and increase of tax expense. According to the disclosed figures, VOIC records BV of JD8.47 and P/BV of 1.70x. In the same context, Birzeit Pharmaceuticals BPC noted posting net income attributable to the shareholders of the parent company of $5.54 million in H1 2018 ;down by 7.79% than the corresponding period of 2017. This followed an increase of the company’s cost of sale, general and administrative, selling and advertising expenses. According to the disclosed figures, BPC records BV of $3.64, and P/BV of 1.44x
|
|